Answers are grounded in this paper and cite their sources.
Experimental study demonstrates SUCNR1-driven macrophage chemotaxis aggravates inflammation in obesity models, suggesting a therapeutic target for diabetes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Diepen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: